Overview
- 9 inspections across 9 sites are on record.
- 13 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-02-06.
At a glance
Inspections
9
Sites
9
Observations
13
Career since
Apr 2017
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Ionetix Corporation | 6 Feb 2025 | Human Drugs | On file |
| Lyophilization Services of New England, Inc. dba PCI Pharma Services | 27 Sep 2023 | Human Drugs | View 483 → |
| Evive Biopharmaceutical (Beijing), Ltd. | 7 Jun 2023 | Human Drugs | On file |
| Suzhou Union Biopharm Co., Ltd. | 26 May 2023 | Human Drugs | On file |
| Smith & Nephew Wound Management | 30 Sep 2022 | Human Drugs | On file |
Sites inspected
Ionetix CorporationKnoxville, United States1 insp.
Lyophilization Services of New England, Inc. dba PCI Pharma ServicesBedford, United States1 insp.
Evive Biopharmaceutical (Beijing), Ltd.Beijing, China1 insp.
Suzhou Union Biopharm Co., Ltd.Suzhou, China1 insp.
Smith & Nephew Wound ManagementFort Worth, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Laurimer Kuilan-Torres2 shared
Wendy G Tan2 shared
Eric L Dong2 shared
Samuel J Arsenault1 shared
Erik W Koester1 shared
Sean R Marcsisin1 shared
Peter E Baker1 shared
Meisha R Sampson1 shared
Full investigator report
Get the verbatim findings behind Lane V Christensen's 13 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site